Roivant Sciences Ltd. (NASDAQ:ROIV) is compared against other top mid cap biotech stocks. Analysts discuss the oversaturation in the biotech sector, with many companies having enterprise values in negative territory, suggesting a need to streamline assets and focus on value creation.